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Abstract
This article outlines the evolution of a community pharmacy-based supervised consumption of
methadone program in Grater Glasgow. The formalization of this program in 1994 promoted full
patient compliance with the methadone regimen and reduced seepage of the drug to the illicit
market. 184 of the area's 215 community pharmacies now dispense methadone for the treatment
of opiate dependence. Of these, 173 have a supplementary contract with the local health board to
supervise the consumption of methadone on their premises. In addition 15 of "methadone"
pharmacists are involved in the provision of a pharmacy based needle exchange scheme. This has
been shown to be the most efficient and cost effective method of delivering clean injecting
equipment to injecting drug users in the Greater Glasgow area. Glasgow's pharmacists' have now
been involved in the methadone and needle exchange programs for more than ten years. The
support needed by pharmacists and the steps that have been put in place to provide this level of
commitment are described. The development of the Glasgow pharmacy based services to drug
users has had a major impact on practice elsewhere in the United Kingdom.
Introduction
Over the past ten years the involvement of Glasgow's com-
munity pharmacists in the area's methadone maintenance
program has increased dramatically. In 1993 a major
review of drugs services in Glasgow suggested that the
high prevalence of injecting drug use prior to 1993 was
because, before that date, little use was made of "success-
ful" substitute prescribing of methadone [1].
This 1993 report proposed new service developments
including the setting up of a specialist service and a drug
crisis center. Methadone was recognized as the main ther-
apeutic intervention, as it possessed the best chance of
success, in terms of reducing morbidity and mortality.
General (office based medical) practice was identified as
the most appropriate setting for this to be carried out [2].
The 1995 report of the (Scottish) Ministerial Drugs Task
Force "Drugs in Scotland: Meeting the Challenge stated
that 'there was considerable potential for pharmacists to
play an even greater role in "frontline" services to drug
misusers. This report recommended that health boards
should consider how best this could be developed [3].
In the United Kingdom, a special license is not required by
a medical practitioner to prescribe methadone for the
treatment of addiction or organic disease. However, meth-
adone prescriptions must satisfy certain statutory require-
ments. Valid prescriptions can be dispensed at any
registered community pharmacy. There is no legal require-
ment for methadone prescriptions to be dispensed daily
nor for the consumption of the doses to be supervised [4].
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Until the development of the Glasgow supervised metha-
done program it was common practice in the United King-
dom for methadone to be supplied to patients to take
away for consumption elsewhere. The dispensing of a sup-
ply for a whole week or longer was commonplace and a
supply for one month was not unusual [5].
Anecdotally the catalyst for what has become the pharma-
cist-supervised consumption of methadone program was
a personal request from one general practitioner (GP) to
her local community pharmacist in 1992[6]. The pharma-
cist was asked if she would be prepared to supervise the
consumption of methadone in her pharmacy on a daily
basis for one specific patient about whom the GP was con-
cerned. The success that resulted from this intervention
led to the emulation of the idea by other local GPs and
pharmacists.
Another reason for supervised consumption of metha-
done in Glasgow was previous experience of an unstruc-
tured and unsupervised system in the late 1970s-early
1980s. Public opinion was extremely antagonistic to
methadone as a treatment modality. Great caution was
thus required to gain acceptance of its reintroduction as a
treatment option. To this day there is still a high level of
public resistance to the concept that methadone is the
drug of choice for the treatment of opiate dependence.
By the time of the Health Board review in 1993, a small
number of prescribing GPs had followed the example of
their colleague. In 1994, when the Glasgow Drug Problem
Service was set up, it was decided to actively promote the
concept of supervised consumption of methadone in
community pharmacies. In 1997 Scottish Office Depart-
ment of Health published guidance on the planning and
provision of Drug Misuse Services and cited supervised
methadone consumption by community pharmacists in
Glasgow as innovative practice in drug misuse services [7].
In 1999 the United Kingdom Departments of Health pub-
lished "Drug Misuse and Dependence – Guidelines on
Clinical Management" [8]. These guidelines advised that
in order to ensure compliance and reduce diversion new
prescriptions [of methadone] should be taken under daily
supervision for a minimum of three months.
In the same year the Greater Glasgow Drug Action Team
(DAT) published its strategy for 1999–2003 [9]. The
DAT's action plan listed a number of specific objectives
including:
 To reduce the sharing of injecting equipment
 To reduce the frequency of drug injecting
 To reduce levels of drug use among current drug users
In the following year a report from the UK Advisory Coun-
cil on the Misuse of Drugs (ACMD) went even further by
advising that normal practice should be for methadone to
be taken under daily supervision for six months or longer
[10]. The ACMD report went on to recommend that this "
should be varied only exceptionally, and if a strong case
can be made out in the individual instance".
The number of Glasgow pharmacies dispensing prescrip-
tions of methadone for the treatment of opiate addiction
has steadily increased from 46% (97/212) in 1994 to 84%
(181/215) in 2003. The number of pharmacies where
supervised consumption (self-administration) of doses of
methadone on the premises takes place has increased
from 20% (43/212) in 1994 to 80% (173/215) in 2003.
The number of patients visiting the pharmacies has
increased from an estimated 2800 in 1997/8 to 6300 in
2003[11]. In contrast, the number of pharmacies offering
a needle exchange service rose from 8 active participants
in 1996 to 15 in 2002/3. A major review of Glasgow's nee-
dle exchange scheme in 2001 recommended that this
number should be increased by 100% to 30 [12]. Finan-
cial constraints meant that the expansion was delayed but
on target to be completed by early 2005. In addition, the
views, beliefs, attitudes and objections of residents, other
businesses and community representatives must be taken
into account when a new pharmacy exchange is opened.
These factors mean that it can take longer than anticipated
to complete the process of opening a new exchange.
A Scottish Executive (Scottish Government): Effective
Interventions Unit research report highlighted the success
of Glasgow's existing pharmacy needle exchanges
between 1997 and 2002. Over that period the total
number of attendances at pharmacy exchanges rose by
686% from 11589 in 1996/7 to 79493 in 2001/2. There
was a similar percentage increase in the number of sets of
equipment from 8014 in 1996/97 to 558176 in 2001/02.
The percentage of used equipment returned to the phar-
macies for disposal rose from 70% in 1996/7 to 86% in
2001/02 [13]. The data used to produce the report are rou-
tinely collected at all needle exchange outlets in Glasgow.
A common data collection form is used. This made it pos-
sible to compare activity at the pharmacies with the other
outlets. Over the study period the number of new clients
attending the pharmacy exchanges increased by 474%
from 220 in 1996/97 to 1262 in 2001/02. The number of
attendances increased by 686% from 11589 to 70493.
In terms of the national prevalence of problematic drug
misuse it was estimated that there were 55,800 individu-
als misusing opiates and benzodiazepines in the year
2000 within Scotland. These figures correspond to a
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prevalence rate of 2% in the Scottish population aged
between 15 and 54 (95% CI 1.5–2.7%) The minimum
number of drug users identified as being in contact with
services or identifiable from criminal justice sources was
22,795 (40% of estimated total)[14]. For Glasgow the
2000 estimates were 15,975 problem users giving a prev-
alence of 3.1% of the population between the ages of 15
and 54 [15].
As previously mentioned, there are 215 community phar-
macies operating within the Greater Glasgow area. They
serve a population of about 900,000 covering the City of
Glasgow, the whole of the local authority area of East
Dumbartonshire and parts of North and South Lanark-
shire and East Renfrewshire. Though most of the area is
inner city or urban there are some parts of the Lanark-
shires and East Dumbartonshire that are rural in nature.
The dispensing of National Health Service (NHS) pre-
scriptions and other pharmaceutical services paid for by
the NHS comprise approximately 80% or more of the
business of a majority of pharmacies in Scotland. The
supervision of the consumption of methadone by patients
attending the pharmacy and the provision of pharmacy-
based needle exchange service are both considered to be
supplementary NHS services and are paid for by the
health service. In order to receive a contract to provide
such services pharmacists must have undertaken specified
training programs and provide the service to set standards
and criteria. Both schemes attract an annual retainer fee
together with an additional fee for each supervision or
needle exchange supply.
Very soon after the inception of the supervised metha-
done program in 1994/5 it was recognized that the partic-
ipating pharmacists were in need of specific professional,
clinical and practical support.
Professional support
A senior pharmacist with specific expertise in the field of
drug misuse was appointed to the newly created post of
Area Pharmacy Specialist-Drug Misuse in early 1996. The
original job description stated that the duties of the post-
holder were to provide advice and support to the Greater
Glasgow Health Board, hospital trusts, medical and phar-
maceutical practitioners and others on all pharmaceutical
matters that relate to drug misuse. The key functions were
to: -
 Monitor and evaluate the supervised consumption of
methadone program in terms of cost and quality of service
 Provide support/advice to community pharmacists
involved in the continuing care of drug misusing patients
 Provide education and training to pharmacists and
other health professionals on pharmaceutical aspects of
drug misuse
 Undertake and encourage clinical audit and practice
research in aspects of drug misuse
 Provide direct liaison between the Glasgow Drug Prob-
lem Service and hospital and community pharmaceuticals
services
 Provide advice to pharmacists supporting drug using
patients on topics such as oral health and safe storage of
medicines
 Provide pharmaceutical advice and expertise to Base 75
(Drop in center for Women Street Workers) and the Glas-
gow Drug Crisis Centre, including formulary
development
Within a few months it was recognized that co-ordination
of the pharmacy needle exchange scheme should be
added to the list of functions. Previously a senior pharma-
cist working in HIV and infectious diseases had under-
taken this role in an ad hoc manner.
Over the years as the number of pharmacies involved in
the program and the number of patients increased it
became clear that it was becoming increasingly difficult
for one person to effectively undertake both functions.
Other professionals have recognized that community
pharmacists are an important but neglected resource in
terms of patient treatment and care. Community pharma-
cists interact with drug users on a daily basis at least six
times a week, within their own community and in a non-
threatening environment. Nevertheless, the advice or
opinion of community pharmcists was rarely, if ever,
sought when decisions were made on a patent's future
treatment. In 2002 a "Peripatetic Pharmacist" was
appointed on a trial basis. The function of this post was to
provide an effective and valued range of support services
to community pharmacists in a clearly defined geographic
area within Greater Glasgow. The scope of this ancillary
post was to:
 Facilitate the development of a range of opportunities
for community pharmacists to play a more active role in
the care and treatment of problem drug users
 Provide locum cover so that individual community
pharmacists could attend case conferences, assessment
meetings, etc., relating to individual patients
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 Provide locum cover so the individual pharmacists
could attend GP practice multi-professional/disciplinary
training sessions
 Facilitate the delivery of a range of development and
support work to community pharmacies
 Support practitioner networks
Education and training
In the United Kingdom there are four national continuing
post-qualification pharmaceutical organizations for phar-
macists, one for each of the "Home Countries". In 1996
the Scottish Centre for Post-Qualification Pharmaceutical
Education (SCPPE) published a distance learning package
"Pharmaceutical Aspects of Methadone Prescribing" that
includes 20 questions that can be returned to the Centre
for marking [16]. Since publication of the module any
pharmacist wishing to be contracted to provide a super-
vised methadone service must provide the Health Board
with evidence of completion of this package. In 1999
another package "Pharmaceutical Care of the Drug Mis-
user" was published. This package deals mainly with harm
reduction, needle exchange and blood borne viruses [17].
Pharmacists contracted to provide a needle exchange serv-
ice are required to prove completion of this package.
In addition pharmacists are encouraged to attend study
multidisciplinary study evenings. There is an annual
meeting and training evening for the needle exchange
pharmacists and their staff. In the last two years a training
program has been developed for "Frontline Staff". These
are pharmacy and general practice staff members. These
staff members are often the first contacts that a drug user
has when attending a GP's surgery or pharmacy.
Outcomes
Treatment of opiate-dependent drug injectors with meth-
adone in a community wide general practitioner centred
scheme, with supervised daily consumption of metha-
done, is associated with major beneficial change for a sub-
stantial proportion of patients [20].
There has been a 686% increase in the numbers of sets of
injecting equipment issued by pharmacies from 8014 in
1996/97 to 558176 in 2001/02. The percentage of used
equipment returned to the pharmacies for disposal rose
from 70% in 1996/97 to 86% in 2001/02 [20].
Comparison of 2002 data from the Scottish Drug Misuse
database [21] (Table 1) shows that for the year although
Glasgow has a higher level of persons reported to the data-
base and the higher level of prescribing of methadone
than is the case in Edinburgh (Lothian), it has the lowest
level of persons reported as using illicit methadone.
Lothian Health Board area has a much lower level of
supervised consumption of methadone than is the norm
in Glasgow [22] yet it has a much higher number of per-
sons reported as being addicted to illicit methadone.
A recently published report on the role of methadone in
drug related deaths in the west of Scotland found that a
growing prevalence of heroin misuse has resulted in an
increase in the number of individuals entering metha-
done maintenance programs. Despite a continuing
increase in the amount of methadone prescribed, metha-
done deaths in Strathclyde 9the police area covering Glas-
gow and the West of Scotland) have decreased since 1996
due possible to changes both in prescribing and clinical
care [23]. The report concluded that, along with the find-
ings of a "Confidential Inquiry, " increased and wide-
spread supervision implemented by pharmacists have
been major factors in decreasing deaths involving
methadone".
Since the appointment of Glasgow's Area Pharmacy Spe-
cialist-Drug Misuse in 1996, several other Scottish Health
Boards have recognized the importance of supporting
pharmacists involved in this area of practice. Six more
Scottish Health Boards have created similar posts
although one of the smallest failed to appoint due to lack
of applicants. Of the five remaining Scottish Health
Boards, at least two are actively considering the creation of
Area Pharmacy Specialist-Drug Misuse posts.
A Peripatetic Pharmacist pilot proved to be very successful
and popular with the pharmacists in the area covered by
the project. In particular, the pharmacists welcomed the
opportunity to attend practice meetings and case confer-
ences. Following a major review of treatment services in
Glasgow it is hoped that it will be possible to create three
such posts to cover the whole of the health board area.
Evaluation of the peripatetic pharmacist post highlighted
the benefits of training, support and advice to community
pharmacists [21]. Together the posts of Area Pharmacy
Specialist and Peripatetic Pharmacist Drug Misuse are
viewed as a resource of value to other health and social
work colleagues and promote effective multidisciplinary
care of the drug misuser.
The planned expansion of the pharmacy needle exchange
scheme led to the recognition that it required its own
coordinator. More support than was available for the Area
Specialist. A separate Pharmacy Needle Exchange Co-ordi-
nator post was created in July 2003 with the express remit
of taking forward the recommendations of the review and
of increasing the number of participants in the scheme
from15 to 30 by 2005. The coordinator will liaise with the
manufacturer and supplier of the needle exchange packs,
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arrange training of pharmacists and staff, organize Hep
A&B vaccination of personnel, deal with local community
groups, residents etc., and arrange for the collection and
safe destruction of returned waste.
In order to allow the community pharmacist to fully par-
ticipate in the integrated care of the drug misuser and
maximize their role in harm reduction, it is essential that
training and support mechanisms provided by the sup-
port posts are continued and extended.
It can be seen that community pharmacists have a vital
role to play in harm reduction. Unlike other health-care
professionals, pharmacists have a unique accessibility to
the general population due to their open availability and
multiple pharmacy locations. This is an important factor
that should be utilized to maximize their important harm
reduction role.
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